In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to ...

Early reports from a recent study suggest that when it comes to a common cancer treatment, appointment timing may in fact be a very big deal. At a June meeting of the American Society of Clinical ...